Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trialTalmadge E. King, Roland M. du Bois, Javier Szwarcberg et al.|The Lancet|2009Cited by 530
Forced Vital Capacity in Patients with Idiopathic Pulmonary Fibrosis: Test Properties and Minimal Clinically Important DifferenceRoland M. du Bois, Athol U. Wells, Derek Weycker et al.|American Journal of Respiratory and Critical Care Medicine|2011Cited by 523
Six-Minute-Walk Test in Idiopathic Pulmonary Fibrosis: Test Validation and Minimal Clinically Important DifferenceRoland M. du Bois, Talmadge E. King, Derek Weycker et al.|American Journal of Respiratory and Critical Care Medicine|2010Cited by 457
Ascertainment of Individual Risk of Mortality for Patients with Idiopathic Pulmonary FibrosisRoland M. du Bois, Talmadge E. King, Derek Weycker et al.|American Journal of Respiratory and Critical Care Medicine|2011Cited by 429